Tweet

VRCC To Participate In Clinical Trial Evaluating The Efficacy Of A New Drug To Treat Dogs With Inoperable Grade 2 & 3 Mast Cell Tumours

Author: VRCC
Posted: Wednesday 20th May, 2009. 00:00:00

VRCC is participating in a ‘Clinical Trial’ evaluating the efficacy of a New Drug to treat Dogs with inoperable Grade 2 & 3 Mast Cell Tumours

VRCC offers all the most modern treatments for Dogs with Mast Cell Tumours but this ‘Trial’ treatment is now available at VRCC for Dogs where current treatment may not be appropriate or where clients do not or are unable to pursue the conventional route.

For full details contact:

Beatriz Balana Tapia or Dr Susan North at:
VRCC Veterinary Referrals
No1 Bramston Way
Southfields. Laindon. Essex. SS15 6TP
Te: 01268 564664

This article has been viewed 861 times.

 

Comments about this article